Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
EXCiPACT
EXCiPACT
Activities:
Regulatory
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Illinois Corn Processing site receives EXCiPACT certification
The certificate demonstrates the site manufactures ethyl alcohol intended for use as a pharmaceutical excipient according to the 2017 EXCiPACT GMP certification standard
Regulatory
JRS Pharma and Gujurat Microwax achieve EXCiPACT certification
EXCiPACT has certified sites in 21 countries to date including the UK, US, Japan and China
Ingredients
Colorcon Westpoint site gains EXCiPACT GMP and GDP Certificate from SGS
Site in Pennsylvania manufactures and distributes lake pigments for use as pharmaceutical excipients
Regulatory
SGS certifies Valtris Speciality Chemical site as GMP
Certification body of EXCiPACT, SGS, has certified that the Cleveland site manufactures metal stearate to GMP standard
EXCiPACT GMP/GDP Certification Scheme
20 March 2019 | Seminar | Frankfurt, Germany
Manufacturing
Qualicaps Romania gains EXCiPACT GMP certification
The certification scope covers the manufacture of gelatin capsule shells for the pharmaceutical and consumer health industries
Regulatory
SGS certifies Dow's Stade site with EXCiPACT GMP standard
The certificate demonstrates that this site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard
Subscribe now